Changes

'''Remdesivir''' is an overpriced, sometimes harmful and mostly ineffective patented medication being promoted by [[liberal]]s to treat [[coronavirus]].  It is administered intravenously and thus requires a very costly 5-day stay in a hospital, in addition to thousands of dollars per patient charged by a pharmaceutical company for the medication itself.<ref>https://www.cbsnews.com/news/gilead-coronavirus-treatment-remdesivir-private-insurance-cost/</ref>  Although remdesivir was heavily touted by [[liberal]]s, on Oct. 16 [[CNN]] admitted, "Big global study finds remdesivir doesn't help Covid-19 patients."<ref>https://www.cnn.com/2020/10/15/health/remdesivir-covid-who-trial-mortality/index.html</ref>

'''Remdesivir''' is an overpriced, sometimes harmful and mostly ineffective patented medication being promoted by [[liberal]]s to treat [[coronavirus]].  It is administered intravenously and thus requires a very costly 5-day stay in a hospital, in addition to thousands of dollars per patient charged by a pharmaceutical company for the medication itself.<ref>https://www.cbsnews.com/news/gilead-coronavirus-treatment-remdesivir-private-insurance-cost/</ref>  Although remdesivir was heavily touted by [[liberal]]s, on Oct. 16 [[CNN]] admitted, "Big global study finds remdesivir doesn't help Covid-19 patients."<ref>https://www.cnn.com/2020/10/15/health/remdesivir-covid-who-trial-mortality/index.html</ref>

On November 19, 2020, "A [[World Health Organization]] panel is now recommending against the use of the antiviral remdesivir in hospitalized Covid-19 patients, saying there is no evidence that the drug — which U.S. regulators have approved for the treatment of the coronavirus — improves mortality."<ref>https://www.statnews.com/2020/11/19/who-recommends-against-remdesivir-covid-19/</ref>

As of November 19, 2020, "A [[World Health Organization]] panel is now recommending against the use of the antiviral remdesivir in hospitalized Covid-19 patients, saying there is no evidence that the drug — which U.S. regulators have approved for the treatment of the coronavirus — improves mortality."<ref>https://www.statnews.com/2020/11/19/who-recommends-against-remdesivir-covid-19/</ref>

Remdesivir depends on a very specific enzyme and thus might not work if its conformation is slightly changed. The overall costs, including hospital expenses, for administering remdesivir to a patient can be as high as $20,000 for a full treatment.

Remdesivir depends on a very specific enzyme and thus might not work if its conformation is slightly changed. The overall costs, including hospital expenses, for administering remdesivir to a patient can be as high as $20,000 for a full treatment.